TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3%
Mon, 5 Nov

TORRENT PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m14,29018,72018,9401.2%32.5%
Other incomeRs m780270100-63.0%-87.2%
TurnoverRs m15,07018,99019,0400.3%26.3%
ExpensesRs m11,00013,95014,2101.9%29.2%
Gross profitRs m3,2904,7704,730-0.8%43.8%
DepreciationRs m8401,5001,5201.3%81.0%
InterestRs m5101,2201,2603.3%147.1%
Profit before taxRs m2,7202,3202,050-11.6%-24.6%
TaxRs m680690260-62.3%-61.8%
Profit after taxRs m2,0401,6301,7909.8%-12.3%
Gross profit margin%23.025.525.0
Effective tax rate%25.029.712.7
Net profit margin%13.58.69.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 32.5% on a year-on-year (YoY) basis. The expenses were up by 29.2% YoY during the same period.
  • The company's operating profit increased by 43.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.0% in 2QFY19 as against 23.0% in 2QFY18.
  • Depreciation charges increased by 81.0% and finance costs increased by 147.1% YoY, respectively.
  • Other income declined by 87.2% YoY during the quarter.
  • Net profit for the quarter declined by 12.3% YoY. Net profit margins during the quarter declined from 13.5% in 2QFY18 to 9.4% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 1.2% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.9% QoQ during the same period.
  • The company's operating profit declined by 0.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 25.0% in 2QFY19 as against 25.5% in 1QFY18.
  • Net profit for the quarter increased by 9.8% QoQ, while net profit margins increased from 8.6% in 1QFY18 to 9.4% in 2QFY19.

To see how TORRENT PHARMA has performed over the last eight quarters, please visit here.

TORRENT PHARMA Share Price Performance

Over the last one year, TORRENT PHARMA share price has moved up from Rs 1,315.3 to Rs 1,581.1, registering a Gain of Rs 265.8 or around 20.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,404.6 (down 1.1%). Over the last one year it has moved down from 14,530.4 to 14,404.6, a gain of 126 points (down 0.9%).

Overall, the S&P BSE SENSEX is up 3.8% over the year.

Current Valuations

At the current price of Rs 1,581.1, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 42.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 5.8 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Nov 18, 2019 11:27 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS